Article Text

Download PDFPDF

4CPS-024 Pharmaceutical interviews dedicated to vaccination: what role for the clinical pharmacist in monitoring the vaccination coverage of at-risk patients?
  1. AL Antoine1,
  2. J Thelen1,
  3. C Ficko2,
  4. S Khenifer3,
  5. AC Cuquel1,
  6. V Lamand1
  1. 1Bégin Military Teaching Hospital, Hospital Pharmacy, Saint-Mande, France
  2. 2Bégin Military Teaching Hospital, Infectious and Tropical Diseases, Saint-Mande, France
  3. 3Bégin Military Teaching Hospital, Oncology, Saint-Mande, France


Background and importance Immunocompromised people and patients with chronic diseases require the application of specific vaccination guidelines. An immunisation assistance tool integrated into the computerised patient record (CPR) has been developed in our institution. Its impact has been evaluated in patients receiving injectable anticancer drugs (IAD) in an oncological indication.

Aim and objectives Propose pharmaceutical interviews (PI) dedicated to vaccination integrating the filling of the immunisation assistance tool and analyse the place of the clinical pharmacist in the monitoring of the vaccination coverage of at-risk patients.

Material and methods Over a 2-month period, 130 day patients receiving IAD were included. Patients received a PI conducted by a pharmacist or pharmacy student. They were informed of the vaccinations indicated in their situation and were given a dedicated flyer. Interviews were conducted using motivational techniques. At the end of the PI, an intervention was conducted with prescribers through a report incorporated into the CPR.

Results A total of 130 patients were eligible. Pharmaceutical interviews could be performed for 84.6% (n=110) of the included patients. The reasons for non-implementation were patient refusal (9.2%, n=12) or patient unavailability (6.2%, n=8). The median duration of a PI was 10 min (5 min; 30 min), mobilising half a full-time equivalent per day. Only 20.9% (n=23) of patients presented a vaccination record. The attending physician was contacted for 24.5% (n=27) of patients and the pharmacy for 20.0% (n=22). Of the patients who received a PI, 60.9% (n=67) were not aware of specific vaccination guidelines applicable to IAD treatment.

Conclusion and relevance As the creation of a vaccination history is time-consuming, the clinical pharmacist plays a facilitating role. Trained in the practice of medication reconciliation, he/she cross-references sources, solicits the attending physician and relies on the corresponding pharmacist. As an educator, he/she also helps to meet patients’ need for information. In face of growing vaccine hesitancy and misinformation, the use of motivational interviewing techniques encourages constructive dialogue and helps to reinforce the acceptability of vaccination, although this aspect was not quantified in our study. However, the maintenance of this activity depends on the presence of a dedicated pharmaceutical resource.

Conflict of interest No conflict of interest

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.